Dr. Stephen Keith Tyring, MD, PhD

Dr. Tyring practices at Dermatological Association of Texas in Houston, Texas.

Dr. Tyring's NPI, 1245227263, was assigned on October 4, 2005. Dr. Tyring graduated from University of Texas Medical Branch at Galveston in 1983. Dr. Tyring holds Texas license G5714.

Dr. Tyring's primary practice is Dermatological Association of Texas, at 1401 Binz St, Houston, TX 77004 in Harris County. The practice phone is (713) 528-8818.

Dr. Tyring's primary practice is Dermatological Association of Texas in Houston, Texas. The medical group on file is UT Physicians. Dmand AI also links Dr. Tyring to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tyring practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Tyring's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Tyring is licensed in Texas.

CMS data shows 2,768 Medicare services from Dr. Tyring across 17 procedure codes in 2024, for 547 Medicare patients. Medicare paid $125,942 for them. Every service was in an office.

CMS counts 547 Medicare patients who saw Dr. Tyring in 2024. The largest group is 65 to 74, with 253 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tyring's median patient age at 69, with 48% women.

In 2024, Dr. Tyring wrote 2,186 Medicare Part D claims for 669 patients. 85% of them were for generic drugs. CMS names the drug for 2,013 of them, across 31 drugs with 11 or more claims each, at $1,833,795 in total drug cost. In 2023, CMS named 1,989 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tyring for performance year 2024, reported individually. Dr. Tyring accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,091 procedures of removal of skin lesions by Dr. Tyring, more than 94% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 306 papers to Dr. Tyring, published from 2006 to 2025. 2018 was the busiest year, with 20. The most frequent topics are Skin Neoplasms, Psoriasis and Double-Blind Method. Dr. Tyring has published most often in Skin Therapy Lett. Dr. Tyring's most frequent co-authors are Hung Q. Doan, MD, PhD, Harrison Phu Nguyen, MBA, MD, MPH and Austinn Christopher Miller.

Dmand AI links Dr. Tyring to 16 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Dermatitis, Atopic, Eczema and Skin Diseases, Eczematous. Eli Lilly and Company sponsors the most, 7. Open Payments lists research payments to Dr. Tyring that name 10 trials.

CMS Open Payments shows 3,052 general payments to Dr. Tyring from 59 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Abbvie Inc. paid the most, $498,531. It also lists 218 research payments totaling $381,089 from 2016 to 2025, naming 10 clinical trials.

Dr. Tyring graduated from University of Texas Medical Branch at Galveston in 1983.